General Information of the Compound
| Compound ID |
CP0394391
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[1-(1H-imidazol-2-yl)-2,3-dihydro-1H-inden-4-yl]pyridine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H15N3
|
||||||||||||||||||
| Molecular Weight |
261.328
|
||||||||||||||||||
| Canonical SMILES |
C1Cc2c(cccc2-c2cccnc2)C1c1ncc[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H15N3/c1-4-13(12-3-2-8-18-11-12)15-6-7-16(14(15)5-1)17-19-9-10-20-17/h1-5,8-11,16H,6-7H2,(H,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
DYDXENMSZODUFG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor
Protein ID: PT01650, Alpha-2A adrenergic receptor